DAX BLUE CHIP INDEX

In listening mode, new Bayer CEO keeps 'open mind' on company split

The 56-year-old chemicals engineer from the U.S., brought over from Swiss rival Roche, begins at a testing time, weighed down by lawsuits claiming Bayer's weed-killer causes cancer and pressure from investors demanding major change.